Thursday, September 21, 2023
No Result
View All Result
  • Media
Support Us
Macdonald-Laurier Institute
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy
      • Energy
      • Environment
    • Foreign Policy
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs
  • Projects
    • The Great Energy Crisis
    • Centre for Advancing Canada’s Interests Abroad
    • Dragon at the Door
    • Canada and the Indo-Pacific Initiative
    • The Transatlantic Program
    • DisInfoWatch.org
    • Competition Policy in Canada
    • Speak for Ourselves
    • Justice Report Card
    • COVID Misery Index
      • Provincial COVID Misery Index
      • Beyond Lockdown
      • COVID and after: A mandate for recovery
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Past Projects
      • The Eavesdropping Dragon: Huawei
      • Talkin’ in the Free World with Mariam Memarsadeghi
      • An Intellectual Property Strategy for Canada
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
      • Straight Talk
      • Labour Market Report
      • Leading Economic Indicator
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Inside Policy
    • Papers
    • Commentary
    • Columns
    • Books
    • Video
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy
      • Energy
      • Environment
    • Foreign Policy
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs
  • Projects
    • The Great Energy Crisis
    • Centre for Advancing Canada’s Interests Abroad
    • Dragon at the Door
    • Canada and the Indo-Pacific Initiative
    • The Transatlantic Program
    • DisInfoWatch.org
    • Competition Policy in Canada
    • Speak for Ourselves
    • Justice Report Card
    • COVID Misery Index
      • Provincial COVID Misery Index
      • Beyond Lockdown
      • COVID and after: A mandate for recovery
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Past Projects
      • The Eavesdropping Dragon: Huawei
      • Talkin’ in the Free World with Mariam Memarsadeghi
      • An Intellectual Property Strategy for Canada
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
      • Straight Talk
      • Labour Market Report
      • Leading Economic Indicator
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Inside Policy
    • Papers
    • Commentary
    • Columns
    • Books
    • Video
No Result
View All Result
Macdonald-Laurier Institute

MLI Paper – Modernizing Canada’s pharmaceutical patent system: An opportunity for more investment and jobs

January 24, 2012
in Domestic Policy Program, Health, Health care - papers, Latest News, Papers, Releases
Reading Time: 3 mins read
A A

New papers recommend changes to Canada’s patent regime

MEDIA RELEASE

January 24, 2012, Ottawa, ON – Canada’s complacency in intellectual property (IP) is threatening its relative position in the global pharmaceutical industry and changes are needed in IP protection to re-establish Canada as a global competitor. According to two new papers published today by the Macdonald-Laurier Institute, understanding the role of patents and modernizing our pharmaceutical patent system could yield many benefits for Canadians, including the opportunity to increase investment and employment as well as reduce trade frictions in order to gain expanded access to foreign markets.

In “The Role of Patents: A Primer”, leading Canadian health economist Professor Brian Ferguson (University of Guelph) provides a comprehensive review of research regarding patents and alternatives. He finds that there are many alternatives to patents, but most research seems to indicate that even with the costs and flaws of the patent system, none have proven themselves superior to patents for encouraging pharmaceutical R&D. Such R&D is indispensable for the discovery of new therapeutic drugs.

Professor Kristina Lybecker (Colorado College) then examines the significant differences that exist across national legal frameworks for the protection of pharmaceutical intellectual property (IP) in “Intellectual Property Law and the Pharmaceutical Industry: An Analysis of the Canadian Framework”. In this study, she finds that IP protection across Canada, the United States, the European Union, South Korea, Japan, Australia, and Brazil varies greatly. By comparing international norms and policies in each country, Lybecker evaluates the characteristics of the legal framework that will best encourage pharmaceutical industry growth. She applies these lessons to Canada and provides four specific recommendations that will strengthen Canada’s intellectual property protection and encourage pharmaceutical innovation:

1. Canada needs orphan drug legislation to encourage R&D for rare diseases: Canada is one of the few industrialized nations lacking a policy for rare diseases. Such legislation in Canada would define a “rare disease” and encourage Canadian firms to intensify their research and develop efforts to discover new therapies for these diseases.

2. Canada needs more expansive data exclusivity protection: Currently, innovative drugs are protected from generic competition through the protection of innovator data for eight years.  Strengthening data exclusivity laws will give innovative firms the incentives to produce the data required for regulatory approval, facilitating the research process and encouraging additional investment.

3. Canada should extend patent protection to accommodate for delays from regulatory approval: Canada fails to provide an extra period of patent protection as compensation for time lost due to regulatory approval delays. The restoration of a patent term extension of zero to five years, as in other countries, would lengthen the effective patent life of innovative therapies, increasing the incentives to invest in the research and development costs that these treatments require.

4. Canada should strengthen its anti-counterfeiting legislation: Criminal sanctions in concert with regulatory provisions will protect Canada from the threat of fraudulent medicines, safeguarding the health of patients and defending the innovative pharmaceutical industry from the theft of intellectual property.

Lybecker concludes, “Canada would benefit from strengthening pharmaceutical intellectual property protection. Pharmaceutical patents protect process and product innovations and incentivize therapies that have enhanced and extend lives on a global scale. This innovation necessitates protection and this protection necessitates a trade-off. Patents provide that, market exclusivity in exchange for continued investment in innovation.”

Brian Ferguson is Professor of Economics at the University of Guelph and Kristina Lybecker is an Assistant Professor of Economics at Colorado College in Colorado Springs. They are authors of Economics of Intellectual Property Protection in the Pharmaceutical Sector, the second instalment in MLI’s Pharmaceutical Series.

For more information or to arrange interviews, please contact Tripti Saha at tripti.saha@macdonaldlaurier.ca or call (613) 482-8327, ext. 105.

-30-

 

 

 

Share this:
Tags: patentpharmaceutical
Previous Post

The Hill Times – Canada’s monumental economic challenge: Our increasingly schizophrenic attitude to natural resource development

Next Post

Vanguard Magazine: A case for the Joint Strike Fighter

Related Posts

Romanian Energy Minister, Sebastian Burduja, talks energy security with Jonathan Berkshire Miller
Video

Romanian Energy Minister, Sebastian Burduja, talks energy security with Jonathan Berkshire Miller

September 21, 2023
Canada-Japan cooperation to counter China’s disinformation campaigns: Charles Burton for Inside Policy
Columns

It’s time for Canada to implement a foreign policy reset: Stephen Nagy in the Japan Times

September 21, 2023
Covid-19, the test bioethics failed: Tom Koch for Inside Policy
Inside Policy

Covid-19, the test bioethics failed: Tom Koch for Inside Policy

September 21, 2023
Next Post

Vanguard Magazine: A case for the Joint Strike Fighter

Newsletter Signup

Follow us on

Macdonald-Laurier Institute

323 Chapel Street, Suite #300
Ottawa, Ontario, K1N 7Z2 Canada

613.482.8327

info@macdonaldlaurier.ca
MLI directory

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

  • Inside Policy Magazine
  • Annual Reports
  • Jobs
  • Privacy Policy

© 2021 Macdonald-Laurier Institute. All Rights reserved.

No Result
View All Result
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy
      • Energy
      • Environment
    • Foreign Policy
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs
  • Projects
    • The Great Energy Crisis
    • Centre for Advancing Canada’s Interests Abroad
    • Dragon at the Door
    • Canada and the Indo-Pacific Initiative
    • The Transatlantic Program
    • DisInfoWatch.org
    • Competition Policy in Canada
    • Speak for Ourselves
    • Justice Report Card
    • COVID Misery Index
      • Provincial COVID Misery Index
      • Beyond Lockdown
      • COVID and after: A mandate for recovery
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Past Projects
      • The Eavesdropping Dragon: Huawei
      • Talkin’ in the Free World with Mariam Memarsadeghi
      • An Intellectual Property Strategy for Canada
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
      • Straight Talk
      • Labour Market Report
      • Leading Economic Indicator
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Inside Policy
    • Papers
    • Commentary
    • Columns
    • Books
    • Video

© 2021 Macdonald-Laurier Institute. All Rights reserved.

IDEAS CHANGE THE WORLD!Have the latest Canadian thought leadership delivered straight to your inbox.
First Name
Last Name
Email address

No thanks, I’m not interested.